Trial intelligence / Profile preview

Urgent Angioplasty for ICAS-related LVO After Thrombectomy

NCT06702657Not yet recruiting

Sponsor
Changhai Hospital
Start
Mar 2025
Primary completion
Nov 2026
01

Overview

Randomised, open-label trial in ischemic stroke and intracranial atherosclerosis (ICAD) (2 arms), sponsored by Changhai Hospital. Primary endpoint: Modified Rankin Scale Score at 90 days. Planned start Mar 2025; status: not yet recruiting.

02

Conditions

ischemic strokeintracranial atherosclerosis (ICAD)

Beyond the preview

Go deeper on NCT06702657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06702657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call